Recruiting
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
NCT07315113
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Maryland Oncology Hematology Calverton, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Willamette Valley Cancer Institute and Research Center Eugene, Oregon, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States